肝性脊髓病研究进展  

Progress of hepatic myelopathy

作　　者：陈志惠[1] 陈东风[1] 

机构地区：[1]第三军医大学大坪医院野战外科研究所消化内科,重庆400042

出　　处：《胃肠病学和肝病学杂志》2016年第7期832-834,共3页Chinese Journal of Gastroenterology and Hepatology

摘　　要：肝性脊髓病(hepatic myelopathy,HM)是肝脏疾病少见的神经系统并发症,以双下肢痉挛性瘫痪为临床特征,目前HM的发病机制尚不明确,治疗方法有限,且临床预后较差。本文就HM的发病机制、诊断及治疗等研究进展作一概述。Hepatic myelopathy （HM） is a rarely neurological complication of liver disease that is characterized by spastic paraparesis. Its pathophysiology is unknown. Treatment for HM is finite and prognosis is poor. In this article, the progress of pathogenesis, diagnosis and treatment of HM were reviewed.

关 键 词：肝性脊髓病 发病机制 治疗 

分 类 号：R575[医药卫生—消化系统]